Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432M
-
Number of holders
-
477
-
Total 13F shares, excl. options
-
328M
-
Shares change
-
-14.5M
-
Total reported value, excl. options
-
$11.6B
-
Value change
-
-$521M
-
Put/Call ratio
-
0.2
-
Number of buys
-
287
-
Number of sells
-
-180
-
Price
-
$35.28
Significant Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q3 2025
542 filings reported holding RPRX - Royalty Pharma plc - Common Stock as of Q3 2025.
Royalty Pharma plc - Common Stock (RPRX) has 477 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 328M shares
of 432M outstanding shares and own 75.82% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (44.2M shares), FMR LLC (28M shares), Capital International Investors (27.2M shares), BlackRock, Inc. (26.2M shares), BAILLIE GIFFORD & CO (17.4M shares), Swedbank AB (12.2M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (12M shares), VANGUARD GROUP INC (10.9M shares), STATE STREET CORP (10.3M shares), and GEODE CAPITAL MANAGEMENT, LLC (7.62M shares).
This table shows the top 477 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.